← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 22, 2019Last known activity
May 31, 2023
Timeline
2010s
- Jan 1, 2016
Harbour BioMed Co. Ltd.— Founded
Drugs by trial phase (8 distinct, 17 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT05824663Lead sponsorPhase 1May 31, 2023
- NCT05790694Lead sponsorPhase 1Aug 26, 2022
- NCT05306444Lead sponsorPhase 1May 12, 2022
- NCT05332210Lead sponsorPhase 3Apr 30, 2022
- NCT05167071Lead sponsorPhase 1Jan 20, 2022
- NCT05149027Lead sponsorPhase 1Dec 20, 2021
- NCT05015127Lead sponsorPhase 2/Phase 3Sep 22, 2021
- NCT05039190Lead sponsorPhase 3Sep 10, 2021
- NCT04866485Lead sponsorPhase 1Jun 14, 2021
- NCT04727164Lead sponsorPhase 1Feb 28, 2021
- NCT04633213Lead sponsorPhase 3Dec 1, 2020
- NCT04428255Lead sponsorPhase 2/Phase 3Jul 21, 2020
- NCT04346888Lead sponsorPhase 2Jun 30, 2020
- NCT04227470Lead sponsorPhase 1Jan 15, 2020
- NCT04135261Lead sponsorPhase 1Sep 24, 2019
Details
- Founded
- Shanghai, CN Jan 1, 2016
- Last known activity
- May 31, 2023